Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Feature Stories

Latest Feature Stories

DR-TB patient Igor in his cell at the Colony 3 TB prison, on the last day of his prison sentence. Up until now, Igor has been sharing a cell with 14 other people. In prison, Igor became a member of the evangelical church and he constantly carries the gospel with him. Photograph by Alexander Glyadyelov
Feature story
Feature story |
18 February 2014
Tuberculosis
Ukraine

The challenges of treating prisoners with Drug Resistant TB

5 min
Feature story |
15 January 2014
Tuberculosis

New TB drugs offer chance of new regimens, experts offer principles for designing new regimens

Feature story |
10 January 2014

MSF working hard to secure safe return of five staff taken in northern Syria

Following confirmation of measles cases among children in several camps for internally displaced people in Bangui, Central African Republic, MSF is vaccinating 68,000 children in five camps in the city in order to prevent an outbreak. Photograph by Pierre Terdjman
Feature story
Feature story |
08 January 2014
Vaccines
Central African Republic

MSF vaccinates 68,000 children in Bangui camps

Former South African president Nelson Mandela has accepted the offer of a beneficiary of the project and has changed his shirt for an HIV-Positive T-shirt. See Zackie (Zackie Achmat of the Treatment Action Campaign, a South African NGO {TAC}) just behind. Photograph by Eric Miller
Feature story
Feature story |
06 December 2013

Hamba kahle Tata Nelson Mandela

Feature story |
06 December 2013
CongoDemocratic Republic of the Congo

Emergency in South Irumu, Orientale Province, Democratic Republic of Congo: Vaccinations and distributions in unstable areas

4 min
Orion (4) is one of MSF’s patients in Tajikistan, one of Asia’s poorest countries, where we run a paediatric TB program. MSF Doctor Ioanna Haziri listens to Orion's lungs and breathing during her check-up of the little boy. Photograph by Wendy Marijnissen
Feature story
Feature story |
07 November 2013
Tuberculosis
Tajikistan

A Boy's Family Joins MSF to Help Him Fight TB Meningitis

5-year-old Umeda has MDR-TB. She is staying with her aunt while her parents are visiting family in another district. Photograph by Wendy Marijnissen
Feature story
Feature story |
07 November 2013
Tuberculosis
Tajikistan

A 5-Year-Old Undergoes MDR-TB Treatment in Tajikistan

3 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury